An Inside Look at Pharma Revenue Management
PharmExec
MARCH 8, 2023
According to the 2023 State of Revenue Report, pharma companies are prioritizing digital transformation while struggling with inflation and supply chain disruptions.
Sat.Mar 04, 2023 - Fri.Mar 10, 2023
105 
Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret
Fierce Pharma
MARCH 10, 2023
Pfizer hopes to nose out competition with approval for new migraine nasal spray Zavzpret kdunleavy Fri, 03/10/2023 - 10:22
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
First nasal monoclonal antibody COVID-19 treatment shows potential
European Pharmaceutical Review
MARCH 9, 2023
A pilot study has demonstrated that a nasal version of the drug Foralumab, an anti-CD3 monoclonal antibody suppressed the inflammatory T cell response and decreased lung inflammation in patients with COVID-19. “This is the first nasal monoclonal antibody—other monoclonal antibody treatments were delivered intravenously and are no longer given as treatment because they are not effective against currently circulating viral variants,” explained Dr Howard Weiner, founder and Director of the Brigham
Mapping the path to future changes in the Journal Citation Reports
Clarivate
MARCH 7, 2023
In July 2022, I shared our plans to extend the Journal Impact Factor (JIF) to all journals in the Web of Science Core Collection from June 2023. This means that this year, journals from the Arts and Humanities Citation Index (AHCI) and the multidisciplinary Emerging Sources Citation Index (ESCI) in the Journal Citation Reports (JCR) will receive a JIF for the first time.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
The Advancements That Let Us Know the Healthcare Revolution Is Here
MedCity News
MARCH 10, 2023
The healthcare industry is one sector that can never grow stagnant.
FDA calls expert hearing for Intercept’s high-profile NASH application for Ocaliva
Fierce Pharma
MARCH 10, 2023
FDA calls expert hearing for Intercept’s high-profile NASH application for Ocaliva aliu Fri, 03/10/2023 - 10:49
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Congress Probes PBM Link to Higher Drug Prices
PharmExec
MARCH 7, 2023
Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.
Consumerism, Customer Experience at Healthcare’s Forefront
MedCity News
MARCH 9, 2023
Healthcare consumerism and prioritizing the customer experience to boost loyalty are key focus areas for providers and payers in the months and years ahead.
Bucking FDA, independent panel backs Roche's lucrative lymphoma expansion bid for Polivy
Fierce Pharma
MARCH 9, 2023
Bucking FDA, independent panel backs Roche's lucrative lymphoma expansion bid for Polivy aliu Thu, 03/09/2023 - 17:22
New cell therapy company will treat solid tumours
European Pharmaceutical Review
MARCH 8, 2023
The joining of Adaptimmune Therapeutics and TCR² Therapeutics will form a new cell therapy company focused on treating solid tumours. Adrian Rawcliffe, Adaptimmune’s Chief Executive Officer asserted that the combined companies will work to gain “approval for the first engineered T-cell receptor (TCR) T-cell therapy for a solid tumour – afami-cel for the treatment of synovial sarcoma.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Generative AI’s Breakthrough Potential in Pharma Marketing
PharmExec
MARCH 10, 2023
How platforms like ChatGPT could transform engagement models.
The Healthcare Interoperability Policies Driving the Conversation at ViVE [Sponsored]
MedCity News
MARCH 6, 2023
Sandy Vance, HLTH’s senior adviser, Interoperability, offered a preview of the interoperability pavilion at ViVE and what she hopes to achieve at the conference this year.
Will the FDA investigate GSK over Zantac? DeLauro wants to know
Fierce Pharma
MARCH 7, 2023
Will the FDA investigate GSK over Zantac?
Moderna opts for Oxfordshire in quest for innovation
PharmaTimes
MARCH 6, 2023
Vaccines developed at the facility will cover a wide range of respiratory diseases
Smartphone Photos to Detect Anemia
Medgadget
MARCH 9, 2023
Researchers at University College London and at the University of Ghana have developed a smartphone-based system that can detect anemia through simple photos taken using the phone’s camera. The technology is intended for use in low- and middle-income countries where access to routine medical diagnostics may be unreliable. The process involves obtaining images of areas of the body which are least pigmented, including the white of the eye, the lower eyelid, and the lip.
Cybersecurity in the Connected Medical Future
MedCity News
MARCH 10, 2023
The healthcare industry of the future will be defined by interoperable systems that need to securely share critical data across devices, distributed applications, and networks.
'The Top Line': Why pharma needs to ramp up its use of AI and machine learning, plus this week's headlines
Fierce Pharma
MARCH 9, 2023
'The Top Line': Why pharma needs to ramp up its use of AI and machine learning, plus this week's headlines tcarey Thu, 03/09/2023 - 15:25
New facility boosts UK’s cell and gene therapy manufacturing capacity
Pharmaceutical Technology
MARCH 10, 2023
On 10 March, the National Health Service Blood and Transplant (NHSBT) opened a new Clinical Biotechnology Centre (CBC) with the aim of improving the UK’s ability to develop and manufacture cell and gene therapies. A £9.3 million ($11 million) grant is being used to build the facility in Bristol where therapies for currently incurable diseases, such as some forms of cancer, sickle cell disease, and cystic fibrosis can be manufactured.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Could default eligibility improve clinical trial enrolment?
European Pharmaceutical Review
MARCH 9, 2023
A new approach developed at the Medical University of South Carolina (MUSC) aiming to improve clinical trial eligibility has shown positive results. The South Carolina Clinical & Translational Research (SCTR) Institute’s patient outreach recruitment (POR) team and partners made potential patients eligible by default. This enabled them to learn of clinical trials in which they could participate.
3 Keys to Better Cybersecurity
MedCity News
MARCH 10, 2023
As companies review their processes, below are three approaches they can keep top of mind — namely, increasing employee training and utilizing technology as safeguards, making a point to learn and change processes following attacks, and prioritizing vetting partners’ security.
In SCOTUS filing, Amgen claps back at Sanofi and Regeneron in long-running patent feud
Fierce Pharma
MARCH 9, 2023
In SCOTUS filing, Amgen claps back at Sanofi and Regeneron in long-running patent feud fkansteiner Thu, 03/09/2023 - 08:45
Eli Lilly places price cap of $35 on out-of-pocket insulin cost
Pharmaceutical Technology
MARCH 8, 2023
Eli Lilly has announced that it will reduce the price of its most commonly used insulin, Humalog, in the US, by 70% and cap the out-of-pocket cost for those on commercial insurance at $35. This follows on from recent US federal action, the Inflation Reduction Act, that legislated reducing the Medicare beneficiary insulin out-of-pocket costs at $35 a month.
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Temperature-stable tuberculosis vaccine induces immune response
European Pharmaceutical Review
MARCH 6, 2023
The first clinical trial of any subunit tuberculosis (TB) vaccine in a temperature-stable form has found that ID93+GLA-SE, a freeze-dried vaccine, was safe. Investigators assessed whether administering a temperature-stable vaccine containing both ID93 and GLA-SE in a single vial would be as effective at inducing an immune response as a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two vials and combined prior to injection.
Lawmakers Are Cracking Down on Companies Using Health Data for Advertising
MedCity News
MARCH 8, 2023
Three senators recently introduced legislation that would ban the use of health data for advertising and marketing purposes. The proposed legislation comes amid media reports claiming that data brokers are selling social media companies patients’ location data, as well as reports that hospitals and digital health startups are collecting patients’ online data and sharing it with tech giants such as Facebook and Google.
Gilead Sciences, after long battle against HIV drug fraudsters, scores $175.2M in judgements
Fierce Pharma
MARCH 10, 2023
Gilead Sciences, after long battle against HIV drug fraudsters, scores $175.
Incannex partners with Catalent to manufacture psilocybin
Pharmaceutical Technology
MARCH 6, 2023
Incannex Healthcare has collaborated with New Jersey-based pharma company Catalent for the development and manufacturing of a cGMP-grade psilocybin drug product for clinical trials and potential commercial use. The drug product is designed for use in the psilocybin-assisted psychotherapy drug development programme of Incannex for generalised anxiety disorder.
How to Stay Competitive in the Evolving State of Martech
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
Enhancing bioavailability in ocular drug delivery
European Pharmaceutical Review
MARCH 10, 2023
A review by researchers on ocular drug delivery discussed strategies that could enhance ocular bioavailability. Currently, effective topical administration is challenging as the industry aims to prolong drug residence time and guarantee appropriate ocular permeation. Although many potent drugs are available to treat most ocular complaints, there are barriers such as tear film, corneal and conjunctival.
Elevance Health: Long Covid Patients Are at Increased Risk for Cardiovascular Problems, Mortality
MedCity News
MARCH 9, 2023
A recent Elevance Health study found that long Covid patients are 2.35 times more likely to experience cardiac arrhythmia and 3.64 times more likely to experience pulmonary embolism. The study also discovered higher mortality rates among long Covid patients.
AstraZeneca’s Imfinzi, Tagrisso deliver lung cancer trial wins. For one, a Keytruda showdown looms
Fierce Pharma
MARCH 9, 2023
AstraZeneca’s Imfinzi, Tagrisso deliver lung cancer trial wins.
CNM-Au8 could address vision problems in multiple sclerosis
Pharmaceutical Technology
MARCH 7, 2023
Clene has presented updated trial results for its Visionary MS Phase II clinical trial for its lead pipeline candidate, CNM-Au8. The trial is investigating CNM-Au8 as a treatment for patients with relapsing forms of multiple sclerosis (MS) with chronic optic neuropathy. The agent has a first-in-class mechanism of action within the MS portfolio, as it is a first drinkable treatment based on a nanocrystalline gold suspension that has reached late-stage development for MS.
Let's personalize your content